TNF and Crohn disease: However, a separate study investigating miRNA polymorphisms and their association with anti-TNF treatment response in Crohn’s disease (CD) found no significant correlations between the dysregulation of specific miRNAs (miR-146, miR-196a, miR-221, miR-224) and clinical outcomes in patients treated with anti-TNF monoclonal antibodies [12].